$AI

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.

Original reporting
Published May 25, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 25, 2026, 2:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound? — source image
Decision brief

The 30-second read

$AINeutralMed
01

Why it matters

The leadership change is positioned as a turnaround lever after preliminary Q4 revenue dropped to $51.6M from $108.7M a year earlier, with the company still unprofitable.

02

Market read

Traders may use the CEO return as a sentiment catalyst, but the cited revenue collapse and lack of profitability keep the risk/reward skewed toward confirmation after upcoming results.

03

What to watch

The article cites health as the prior constraint on Siebel’s sales involvement, but does not quantify pipeline quality, customer retention, or whether revenue decline is structural vs temporary.

Relevance 9/10Timing: Catalyst is immediate (CEO change disclosed May 8); next earnings/revenue prints are the key confirmation window.

Background

C3.ai’s founder/CEO Thomas Siebel stepped down for health reasons, with Stephen Ehikian taking over effective Sept. 1, 2025; the company later considered a sale and sales declined in recent quarters.

Company-level read

Ticker impact

$AINeutralMedium confidence
Context

C3.ai announced Thomas Siebel returned as CEO (May 8) after declining sales and preliminary Q4 revenue fell to $51.6M.

Expected impact

Near-term trading may bounce on CEO-catalyst hopes, but follow-through likely depends on next-quarter revenue stabilization and profitability progress.

Evidence & confidence

The news is leadership-related (sentiment catalyst) while the fundamental datapoint cited is sharply weaker revenue year-over-year and persistent losses, limiting upside conviction.

Market effects

Signals that enterprise AI software vendors still face execution risk even with strong market demand narratives.

Primarily US growth/AI software sentiment; limited direct regional linkage described.

Global AI enterprise spending backdrop remains uncertain; no specific international contract or regulator action cited.

Counterpoint

The CEO return may be largely symbolic if sales execution and demand generation remain unchanged; stock could stay range-bound until profitability metrics improve.

Key entities

  • C3.ai

    Announced Thomas Siebel returned as CEO (as of May 8) amid sharply declining revenue and ongoing losses.

Related articles

$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.